Premium Industrial News

AstraZeneca Building New COVID-19 Vaccine Plant in Germany

AstraZeneca Building New COVID-19 Vaccine Plant in Germany

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 751 Words

GALWAY, IRELAND--February 23, 2021--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--AstraZeneca is planning to build a new COVID-19 vaccine plant in Germany with IDT Biologika to boost vaccine output and overcome problems with initial European supplies.

Within this article: Details new plant plans, partners,

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?